As per Future Market Insights’ latest industry analysis, as per a recent market analysis by Future Market Insights (FMI), global molecular diagnostics market is anticipated to showcase an opulent growth opportunity over the projection period by exhibiting a CAGR of 18% from 2022 to 2032. At present, the market is valued at around US$ 14802.156 Million in 2022 and is anticipated to reach a high of US$ 59882.97671 Million by the year 2032. According to Future Market Insights' historical analysis, the global molecular diagnostics market exhibited a CAGR of 15%.

An inevitable surge in the demand for molecular diagnostics has been witnessed over the past few years and the market is expected to accelerate at a steady pace attributed to its heavy usage within the process of manufacturing a wide range of specialty products like advanced polymers, sealants, additives, specialty paints, pigments, coatings, and more.

A substantial upsurge has been observed in the demand for the molecular diagnostics market in recent years. The global market is expected to progress at a healthy pace attributed to the rising prevalence of infectious diseases and several variants of cancer worldwide. Furthermore, the rising awareness and acceptance of personalized medical doses and increasing biomarker identification are anticipated to help the market development over the assessment period.

Some of the key companies in the market are:

  • ABBOTT LABORATORIES
  • Agilent Technologies Inc.
  • BECTON DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • DANAHER CORPORATION
  • F. HOFFMAN LA-ROCHE LTD.
  • GRIFOLS S.A.
  • HOLOGIC INC.
  • QIAGEN INC.
  • SIEMENS AG (SIEMENS HEALTHINEERS)

Browse More Details@ https://www.futuremarketinsights.com/reports/molecular-diagnostics-market

Key Segments in The Molecular Diagnostics Market

By Product and Service:

  • Reagents and Kits
  • Instruments
  • Service and Software

By Technology:

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INNAT)
  • DNA Sequencing and Next-Generation Sequencing (NGS)
  • In Situ Hybridization (ISH)
  • DNA Microarrays
  • Others

By Application:

  • Infectious Disease Diagnostics
  • Oncology Testing
  • Genetic Testing
  • Others

By End User:

  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Others